Reduction in the Occurrence of Center-Involved Diabetic Macular Edema

NCT00090519 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

731

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: ruboxistaurin
DRUG: placebo

Sponsor

Chromaderm, Inc.